Clean Yield Group’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163K Hold
300
0.04% 162
2026
Q1
$178K Hold
300
0.05% 145
2025
Q4
$146K Hold
300
0.04% 155
2025
Q3
$126K Hold
300
0.04% 155
2025
Q2
$86.2K Hold
300
0.03% 184
2025
Q1
$92.5K Hold
300
0.03% 176
2024
Q4
$106K Hold
300
0.03% 172
2024
Q3
$108K Hold
300
0.03% 173
2024
Q2
$95.6K Hold
300
0.04% 171
2024
Q1
$68.9K Hold
300
0.03% 203
2023
Q4
$66K Hold
300
0.03% 208
2023
Q3
$70.4K Hold
300
0.03% 199
2023
Q2
$66.2K Hold
300
0.03% 214
2023
Q1
$67.2K Hold
300
0.03% 211
2022
Q4
$83.4K Hold
300
0.04% 194
2022
Q3
$63K Hold
300
0.03% 207
2022
Q2
$71K Hold
300
0.03% 207
2022
Q1
$54K Hold
300
0.02% 248
2021
Q4
$65K Hold
300
0.02% 248
2021
Q3
$55K Buy
300
+150
+100% +$29.5K 0.02% 256
2021
Q2
$27K Buy
+150
New +$28.6K 0.01% 303
2021
Q1
Sell
-75
Closed -$11K 359
2020
Q4
$11K Buy
+75
New +$9.84K ﹤0.01% 343
2015
Q3
Sell
-2,225
Closed -$387K 129
2015
Q2
$387K Sell
2,225
-1,570
-41% -$282K 0.18% 99
2015
Q1
$654K Sell
3,795
-9,086
-71% -$1.39M 0.28% 80
2014
Q4
$1.67M Sell
12,881
-1,945
-13% -$251K 0.75% 52
2014
Q3
$1.91M Sell
14,826
-469
-3% -$48.4K 0.92% 40
2014
Q2
$1.35M Buy
15,295
+1,815
+13% +$175K 0.67% 57
2014
Q1
$1.27M Buy
+13,480
New +$1.38M 0.66% 59

Other funds holding UTHR

Clean Yield Group's UTHR Position: Q2 2026 in Review

Clean Yield Group held its United Therapeutics (UTHR) position steady in Q2 2026 at 300 shares worth $163K. The position accounts for 0.04% of the portfolio, ranked #162.

Clean Yield Group first reported a position in UTHR in Q1 2014 and has held it in 28 quarters since. The position peaked at $1.91M in Q3 2014. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Clean Yield Group held 300 shares of United Therapeutics worth $163K as of Q2 2026.
  • Clean Yield Group left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.04% of Clean Yield Group's portfolio in Q2 2026, its #162 holding.
  • Clean Yield Group first reported a position in United Therapeutics in Q1 2014 and has held it in 28 quarters since.
  • Clean Yield Group's United Therapeutics position peaked at $1.91M in Q3 2014.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Clean Yield Group's 13F filing for Q2 2026, filed 5 Aug 2026.